Viewing Study NCT00842712

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:19 PM

Ignite Modification Date: 2025-12-26 @ 10:19 PM

Study NCT ID: NCT00842712

Status: COMPLETED

Last Update Posted: 2017-01-13

First Post: 2009-02-10

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

Sponsor: Merck KGaA, Darmstadt, Germany

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module